Next Generation Sequencing (NGS) Services Market - Global Opportunity Analysis and Industry Forecast (2018-2023)

  • Report ID:MRHC - 10471
  • Pages: 197
  • Mar 2018
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary 

4. Market Share Analysis 


5. Market Insights
    5.1. Introduction
           5.1.1. Drivers
                     5.1.1.1. Plummeting Cost of Sequencing
                     5.1.1.2. Need of Skilled Professionals for Efficient NGS Sample Preparation and Analysis
                     5.1.1.3. Technological Advancements in NGS Services
                     5.1.1.4. Increase in Genome Mapping Programs
                     5.1.1.5. High Cost of Sequencing Infrastructure
           5.1.2. Restraint
                     5.1.2.1. Installation of In-House Sequencing Facilities in Hospitals and Universities
           5.1.3. Opportunities
                     5.1.3.1. Increasing Applications in Cancer and Agrigenomics Research
                     5.1.3.2. Analysis of Complex Sequencing Data
           5.1.4. Challenges
                     5.1.4.1. Accuracy & Standardization Concerns in Diagnostic Testing
                     5.1.4.2. Ethical Issues Related to NIPT

6. Next Generation Sequencing Services Market, by Service Type
    6.1. Introduction
    6.2. Targeted Sequencing
    6.3. RNA Sequencing
    6.4. Exome Sequencing
    6.5. De Novo Sequencing
    6.6. ChIP Sequencing
    6.7. Whole Genome Sequencing
    6.8. Methyl Sequencing
    6.9. Other Services

7. Next Generation Sequencing Services Market, by Technology
    7.1. Introduction
    7.2. Sequencing by Synthesis (SBS)
    7.3. Ion Semiconductor Sequencing (IOS)
    7.4. Single Molecule Real Time Sequencing (SMRT)
    7.5. Nanopore Sequencing
    7.6. True Single Molecule Sequencing (tSMS)

8. Next Generation Sequencing Services Market, by Application
    8.1. Introduction
    8.2. Diagnostics
    8.3. Drug Discovery
    8.4. Biomarker Discovery
    8.5. Agriculture & Animal Research
    8.6. Other Applications

9. Next Generation Sequencing Services Market, by End User
    9.1. Introduction
    9.2. Academic & Research Institutes
    9.3. Pharmaceutical & Biotechnology Industry
    9.4. Hospitals & Clinics
    9.5. Other End Users

10. Next Generation Sequencing Services Market, by Geography
      10.1. Introduction
      10.2. North America
               10.2.1. U.S.
               10.2.2. Canada
      10.3. Europe
               10.3.1. Germany
               10.3.2. France
               10.3.3. U.K.
               10.3.4. Italy
               10.3.5. Spain
               10.3.6. Rest of Europe
      10.4. Asia Pacific
               10.4.1. Japan
               10.4.2. China
               10.4.3. India
               10.4.4. Rest of Asia-Pacific
      10.5. Rest of the World (RoW)
               10.5.1. Latin America
               10.5.2. Middle East & Africa

11. Competitive Landscape
      11.1. Introduction
      11.2. New Service Launches & Enhancements
      11.3. Agreements, Collaborations, and Partnerships
      11.4. Mergers & Acquisition
      11.5. Expansions
      11.6. Other Developments

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Recent Strategic Developments)
      12.1. Illumina, Inc.
      12.2. Qiagen N.V.
      12.3. PerkinElmer, Inc.
      12.4. Eurofins Scientific SE
      12.5. GATC Biotech AG
      12.6. Macrogen, Inc.
      12.7. Genotypic Technology Pvt. Ltd.
      12.8. GENEWIZ, Inc.
      12.9. Beijing Genomics Institute (BGI)
      12.10. SciGenom Labs Pvt. Ltd
      12.11. MedGenome
      12.12. DNA Link, Inc.
      12.13. Otogenetics Corporation
      12.14. Novogene Corporation
      12.15. LGC Limited
      12.16. CD Genomics
      12.17. SeqLL, LLC

13. Appendix
      13.1. Questionnaire
      13.2. Available Customization

List of Tables
Table 1 List of Technological Advancements in NGS Services Market, by Key Company, 2014-2017
Table 2 Global NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 3 Global NGS Targeted Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 4 Global NGS RNA Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 5 Global NGS Exome Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 6 Global NGS De Novo Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 7 Global NGS Chip Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 8 Global NGS Whole Genome Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 9 Global NGS Methyl Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 10 Global NGS Other Sequencing Services Market Size, by Country/Region, 2016-2023 (USD Million)
Table 11 Global NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 12 Global NGS Services Market Size for Sequencing by Synthesis, by Country/Region, 2016-2023 (USD Million)
Table 13 Global NGS Services Market Size for Ion Semiconductor Sequencing, by Country/Region, 2016-2023 (USD Million)
Table 14 Global NGS Services Market Size for Single Molecule Real Time, by Country/Region, 2016-2023 (USD Million)
Table 15 Global NGS Services Market Size for Nanopore Sequencing, by Country/Region, 2016-2023 (USD Million)
Table 16 Global NGS Services Market Size for True Single Molecule Sequencing, by Country/Region, 2016-2023 (USD Million)
Table 17 Global NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 18 Global NGS Services Market Size for Diagnostics, by Country/Region, 2016-2023 (USD Million)
Table 19 Global NGS Services Market Size for Drug Discovery, by Country/Region, 2016-2023 (USD Million)
Table 20 Global NGS Services Market Size for Biomarker Discovery, by Country/Region, 2016-2023 (USD Million)
Table 21 Global NGS Services Market Size for Agriculture and Animal Research, by Country/Region, 2016-2023 (USD Million)
Table 22 Global NGS Services Market Size for Other Applications, by Country/Region, 2016-2023 (USD Million)
Table 23 Global NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 24 Global NGS Services Market Size for Academic & Research Institutes, by Country/Region, 2016-2023 (USD Million)
Table 25 Global NGS Services Market Size for Pharmaceuticals & Biotechnology Industry, by Country/Region, 2016-2023 (USD Million)
Table 26 Global NGS Services Market Size for Hospital & Clinics, by Country/Region, 2016-2023 (USD Million)
Table 27 Global NGS Services Market Size for Other End Users, by Country/Region, 2016-2023 (USD Million)
Table 28 Global NGS Services Market Size, by Geography, 2016-2023 (USD Million)
Table 29 North America: NGS Services Market Size, by Country, 2016-2023 (USD Million)
Table 30 North America: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 31 North America: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 32 North America: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 33 North America: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 34 U.S.: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 35 U.S.: Market Size, by Technology, 2016-2023 (USD Million)
Table 36 U.S.: Market Size, by Application, 2016-2023 (USD Million)
Table 37 U.S.: Market Size, by End User, 2016-2023 (USD Million)
Table 38 Canada: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 39 Canada: Market Size, by Technology, 2016-2023 (USD Million)
Table 40 Canada: Market Size, by Application, 2016-2023 (USD Million)
Table 41 Canada: Market Size, by End User, 2016-2023 (USD Million)
Table 42 Europe: NGS Services Market Size, by Country, 2016-2023 (USD Million)
Table 43 Europe: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 44 Europe: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 45 Europe: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 46 Europe: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 47 Germany: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 48 Germany: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 49 Germany: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 50 Germany: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 51 France: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 52 France: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 53 France: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 54 France: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 55 U.K.: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 56 U.K.: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 57 U.K.: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 58 U.K.: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 59 Italy: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 60 Italy: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 61 Italy: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 62 Italy: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 63 Spain: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 64 Spain: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 65 Spain: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 66 Spain: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 67 RoE: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 68 RoE: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 69 RoE: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 70 RoE: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 71 APAC: NGS Services Market Size, by Country, 2016-2023 (USD Million)
Table 72 APAC: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 73 APAC: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 74 APAC: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 75 APAC: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 76 Japan: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 77 Japan: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 78 Japan: NGS Services Market Size, by Application, 2016-2023 (USD Million)
Table 79 Japan: NGS Services Market Size, by End User, 2016-2023 (USD Million)
Table 80 China: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 81 China: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 82 China: Market Size, by Application, 2016-2023 (USD Million)
Table 83 China: Market Size, by End User, 2016-2023 (USD Million)
Table 84 India: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 85 India: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 86 India: Market Size, by Application, 2016-2023 (USD Million)
Table 87 India: Market Size, by End User, 2016-2023 (USD Million)
Table 88 RoAPAC: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 89 RoAPAC: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 90 RoAPAC: Market Size, by Application, 2016-2023 (USD Million)
Table 91 RoAPAC: Market Size, by End User, 2016-2023 (USD Million)
Table 92 RoW: NGS Services Market Size, by Country, 2016-2023 (USD Million)
Table 93 RoW: NGS Services Market Size, by Service Type, 2018-2023 (USD Million)
Table 94 RoW: NGS Services Market Size, by Technology, 2018-2023 (USD Million)
Table 95 RoW: Market Size, by Application, 2016-2023 (USD Million)
Table 96 RoW: Market Size, by End User, 2016-2023 (USD Million)
Table 97 Latin America: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 98 Latin America: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 99 Latin America: Market Size, by Application, 2016-2023 (USD Million)
Table 100 Latin America: Market Size, by End User, 2016-2023 (USD Million)
Table 101 Middle East & Africa: NGS Services Market Size, by Service Type, 2016-2023 (USD Million)
Table 102 Middle East & Africa: NGS Services Market Size, by Technology, 2016-2023 (USD Million)
Table 103 Middle East & Africa: Market Size, by Application, 2016-2023 (USD Million)
Table 104 Middle East & Africa: Market Size, by End User, 2016-2023 (USD Million)
Table 105 Recent Developments, by Company, 2014-2017
Table 106 New Service Launches & Enhancements, 2014-2017
Table 107 Agreements, Collaborations & Partnerships, 2014-2017
Table 108 Mergers & Acquisitions, 2014-2017
Table 109 Expansions, 2014-2017
Table 110 Other Developments, 2014-2017

List of Figures
Figure 1 Market Ecosystem
Figure 2 Key Stakeholders in NGS Services 
Figure 3 Research Process in NGS Services Market
Figure 4 Key Executives Interviewed
Figure 5 Primary Research Techniques in NGS Services Market
Figure 6 Market Size Estimation in NGS Services
Figure 7 Meticulous Research Estimates: Diagnostics Vs. Biomarker Discovery
Figure 8 Where Are the Opportunities for You?
Figure 9 Key Adopters of NGS Services Market
Figure 10 Academic & Research Institutes Expected to Dominate the Global NGS Services Market by End User (2018-2023)
Figure 11 Significant Government Funding in Asian Countries, An Impetus to the NGS Services Market
Figure 12 Market Share Analysis: Next Generation Sequencing (NGS) Services Industry, 2017
Figure 13 Market Dynamics 
Figure 14 Global NGS Services Market Size, by Service Type, 2018-2023 (USD Million)
Figure 15 Funding for Targeted Sequencing
Figure 16 Global NGS Services Market Size, by Technology, 2018-2023 (USD Million)
Figure 17 Global NGS Services Market Size, by Application, 2018-2023 (USD Million)
Figure 18 Better Diagnostics and Treatment for Tuberculosis
Figure 19 Global NGS Services Market Size, by End User, 2017-2023 (USD Million)
Figure 20 Global Pharmaceutical R&D Spending, 2009-2015
Figure 21 Global NGS Services Market Size, by Geography, 2018-2023 (USD Million)
Figure 22 Number of People Over 65 in the U.S., 2000-2050
Figure 23 Proportion of Canadians Aged 65 and Older with Major Chronic Diseases, 2014
Figure 24 Spending on R&D in Higher Education Sector, by Source of Funding and Scientific Field, 2014/2015
Figure 25 Spending on R&D in Higher Education Sector, by Source of Funding
Figure 26 Population Aged 65 and Over by Region: 2015 and 2050
Figure 27 Germany: Proportional Mortality, 2014
Figure 28 Prevalence of Chronic Diseases Among Patients Over 65 Years of Age Treated in German General Practices, 2016
Figure 29 U.K.: Proportional Mortality, 2014
Figure 30 Composition Expenditure on Research and Development by Various Sectors in the U.K.,2015
Figure 31 Number of Biotechnology Firms in Italy, 2005-2015
Figure 32 R&D Spending by Pharmaceutical Industry in Spain, 2008-2015
Figure 33 Japan: Proportional Mortality, 2014
Figure 34 Life Expectancy in Japan, 2000-2016
Figure 35 China Population Growth Chart
Figure 36 Healthcare Expenditure Per Capita in India, 2010-2014
Figure 37 Healthcare Spending in Brazil, 2007-2016
Figure 38 Latin America’s Aging Population, 2005-2050
Figure 39 Key Growth Strategies Adopted by Leading Players -2014-2017
Figure 40 New Service Launches & Enhancements, by Company, 2014-2017
Figure 41 Agreements, Collaborations, and Partnerships, by Company, 2014-2017
Figure 42 Mergers & Acquisitions, by Company, 2014-2017
Figure 43 Expansions, by Company, 2014-2017
Figure 44 Illumina, Inc.: Financial Overview-2014-2016
Figure 45 Qiagen N.V.: Financial Overview-2014-2016
Figure 46 PerkinElmer, Inc.: Financial Overview-2014-2016
Figure 47 Eurofins Scientific SE: Financial Overview-2014-2016

Next Generation Sequencing (NGS) Services Market Size by Service Type (Targeted sequencing, RNA Sequencing, Exome Sequencing, De Novo Sequencing, ChIP-Sequencing, Whole Genome Sequencing, Methyl Sequencing, and Other Services),Technology [Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing (IOS), Single Molecule Real Time Sequencing (SMRT), Nanopore Sequencing, and True Single Molecule Sequencing (tSMS)], Application (Diagnostics, Drug Discovery, Biomarker Discovery, Agriculture & Animal Research, and Other Applications), End User (Academic& Research Institutes, Pharmaceuticals & Biotechnology Industry, Hospitals & Clinics and Other End Users) – Global Opportunity Analysis and Industry Forecasts To 2023

The recent advances in the field of genomics research over the past years have led to substantial reduction in the cost of genome sequencing. The NGS technology has reduced the cost and increased the speed of DNA sequencing significantly. In genomics research field, sequencing is being applied not only to assemble genomes and to investigate the genetic basis of human diseases, but also to understand the diverse nature of reproductive medicine, oncology and infectious diseases. The cheaper genome sequencing could revolutionize healthcare, allowing doctors to prescribe individualized treatment options for patients. Also, this would enable faster progress in clinical research, pushing research for cancer and other genetically linked diseases forward.

Cancer research has witnessed remarkable advances during the past decade. This has been possible due to advent of NGS that has led to significant increase in understanding of cancer biology and the cooperative roles of the cancer genome, transcriptome, and epigenome. NGS services has made large-scale projects such as The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) feasible, providing researchers with multi-platform data for thousands of tumors from a variety of cancer types and subtypes. This has in turn expanded translational research where data obtained from patient samples inform both research and clinical care. One of the most valuable aspects of NGS is the fact that it can produce an unparalleled amount of data relatively quickly and inexpensively, allowing for comprehensive projects at a scale that would otherwise not be feasible. In-depth characterization of individual tumors is therefore of significant potential benefit to patients, whose treatment could be chosen based on molecular alterations found within their tumor(s). Thus, the technological advancement in NGS services is providing researchers powerful tools to elucidate molecular mechanism related to the various types of cancer across the globe.

The cost of sequencing closely followed a Moore’s law trajectory over the years before 2008; however the introduction of NGS technologies caused costs to fall faster than would be expected by Moore’s law. In 2003, the first time the human genome was sequenced for a price of $2.7 billion. Later, the price of sequencing an average human genome declined from about $10 million to a few thousands in just 6 years of duration (2007-2013). 

Further to this declining price trend, in January 2017, Illumina debuted a new sequencing machine, the NovaSeq (NovaSeq 5000 and NovaSeq 6000), which has ability to sequence an entire genome for less than $100 in fewer than 60 minutes.

Thus, the plummeting cost of DNA sequencingwould enable researchers to perform ever larger studies to correlate genes with medical histories, which will consequently boost the demand for NGS services in near future.

Market Overview 

Global NGS services market is expected to reach USD 2,921.4 million by 2023, supported by a CAGR of 20.1% during the forecast period of 2018 to 2023.

The global NGS services market is mainly driven by the plummeting cost of sequencing, growing need of skilled professionals for efficient NGS sample preparation and analysis, technological advancements in NGS services , increase in genome mapping programs, and high cost of sequencing infrastructure. Further, increasing applications in cancer and agrigenomics research and analysis of complex sequencing data provides significant opportunities to NGS service providers. However, growing installation of in-house sequencing facilities in hospitals and universities may hamper the growth of NGS services market to some extent. 

Analysis of Complex Sequencing Data

The power and widespread availability of Next-Generation Sequencing (NGS) platforms, has significantly broadened the scale of many DNA-sequencing (DNA-Seq) applications, from detecting single nucleotide polymorphisms (SNPs) and copy number variations (CNVs), to assembling genomes or transcriptomes, developing quantitative RNA-sequencing (RNA-Seq) analysis, and detecting epigenetic changes. One of the most challenging aspects in NGS is managing the massive scale of sequencing data. The Genome Analysis Toolkit (GATK) is one of the most widely-utilized software packages in the life sciences developed at the Broad Institute to analyse NGS data. GATK offers a wide variety of tools, with emphasis on variant discovery and genotyping as well as strong focus on data quality assurance. For instance, large scale human medical resequencing projects such as 1000 Genomes and The Cancer Genome Atlasutilizes GATK programming framework, which enables developers and analysts to quickly and easily understand the robust NGS data efficiently.

According to the frontiers in life science, the current sequencing limit is evaluated to be 13 quadrillion DNA bases per year. This has resulted in the urgent need for new databases that can store large volumes of disparate data types. For example, to store 1000 human genomes, the net measure of space needed is roughly three terabytes; however, the storage of raw sequences needs considerably more space. Furthermore, for retrieving and transferring these voluminous data, which is composed of several thousand genomes (as in the ICGC), requires the use of various sequence compression techniques.

As the research area is expanding rapidly, more libraries are moving towards cloud services; hence, the technology has entered into the second phase of its life cycle dominating the IT paradigm. Therefore, the urge for effectively tackling these data has led to an expanded enthusiasm in approaches toward parallelization and dispersed execution of annotation pipelines. Researchers are expecting to develop an improved version of NGS analytics, which could provide filtering, mapping and analysis for very large datasets in a shorter time span and gives promisingly accurate and faster capabilities for the analysis of these high-throughput sequencing data.

Thus, the growing need to handle complex sequencing data coupled with advances in NGS analytics offers immense opportunities for NGS services market.

Market Segmentation 

The global NGS services market is mainly segmented by service type (targeted sequencing, RNA sequencing, exome sequencing, de novo sequencing, ChIP-sequencing, whole genome sequencing, methyl sequencing, and other services), by technology (sequencing by synthesis, ion semiconductor sequencing, single molecule real time sequencing, nanopore sequencing, true single molecule sequencing), by application (diagnostics, drug discovery, biomarker discovery, agriculture & animal research, and other applications), by end user (academic& research institutes, pharmaceuticals & biotechnology industry, hospitals & clinics and other end users), and by geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

Geographic Overview 

Geographically, the global NGS services market is segmented into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa with a further analysis of major countries in these regions. North America accounted for the major share in the global NGS services market in 2017, followed by Europe and Asia-Pacific. The major share of the North American region is mainly attributed to the increasing burden of chronic and infectious diseases, increasing R&D expenditure, and various supportive government initiatives. In addition, the presence of many genomic services providers in this region propels the growth of the market. On the other hand, Asia-Pacific region is projected to grow at the highest CAGR during the forecast period, due to increasing population, rising rate of diseases, growing outsourced research activities in this region, and various government initiatives for the genomic research for understanding the complex biological process and genetic mutation present in life-threatening diseases.

The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, market opportunities and forecast, and regulatory scenario. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

Key players 

The report includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017). The study has also incorporated the detailed profiles of 17 top market players, including detailed financial performance, strategic focus, business overview, and service offerings of each player. The key players in the global NGS services market are Illumina, Inc.(U.S.), Qiagen N.V.(The Netherlands), PerkinElmer, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), GATC Biotech AG (Germany), Macrogen, Inc. (South Korea), Genotypic Technology Pvt. Ltd. (India), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd. (India), MedGenome (India), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Corporation (China), LGC Limited (U.K.), CD Genomics (U.S.), and SeqLL, LLC (U.S.)

Key questions answered in the report- 

Growing genomics research in academic and research institutes and outsourcing of genome testing in biopharmaceutical & biotechnology industry to drive the adoption of NGS services 

  • How does the penetration of NGS services in biopharmaceutical industry differ from that in diagnostics and biomarker discovery applications?
  • What impact does this have on the adoption of NGS services in comparison to other conventional technologies for detection of genetic mutations?

Agriculture & animal research account for a relatively small proportion of all applications of NGS services globally 

  • What factors contribute to the infrequent usage of NGS services for agriculture & animal research?
  • Conversely, which geographic segment is expected to experience the fastest growth for agriculture & animal research?

The North American NGS services market favors both larger and local manufacturers that compete in multiple segments 

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion during the forecast period?
  • What strategies must companies adopt who are looking to enter this market and compete effectively?
  • What are the major drivers, restraints, opportunities, and challenges in the global NGS services market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent new service launches, acquisitions, collaborations, partnerships, and expansions have taken place in the NGS services space. 

  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the NGS services space?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global NGS services market and what share of the market do they hold?
  • What are the local emerging players in the global NGS services market and how do they compete with the global players?

Scope of the Report: 

NGS Services Market by Service Type:

  • Targeted Sequencing
  • RNA Sequencing
  • Exome Sequencing
  • De Novo Sequencing
  • ChIP-Sequencing
  • Whole Genome Sequencing
  • Methyl Sequencing
  • Other Services

NGS Services Market by Technology:

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing (IOS)
  • Single Molecule Real Time Sequencing (SMRT)
  • Nanopore Sequencing
  • True Single Molecule Sequencing (tSMS)

NGS Services Market by Application:

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Agriculture & Animal Research
  • Other Applications 

NGS Services Market by End User:

  • Academic & Research Institutes
  • Pharmaceuticals & Biotechnology Industry
  • Hospitals & Clinics
  • Other End Users

NGS Services Market by Geography:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa

 

Report Name
Full Name
Email
Job Title
Company
Country
Phone Number
--
Your Specific Interest
Captcha
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Healthcare Analytics Connected Health / Digital Health
Download Free Sample
+91-744-778-0008